Tech Company Financing Transactions
Eleven Therapeutics Funding Round
Eleven Therapeutics closed a $22 million Seed funding round on 8/2/2022. Backers included Bill & Melinda Gates Foundation, Entree Capital and Harel Insurance Investments and Financial Services.
Transaction Overview
Company Name
Announced On
8/2/2022
Transaction Type
Venture Equity
Amount
$22,000,000
Round
Seed
Investors
Proceeds Purpose
We focused on advancing nucleic acid therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
99 Ben-Yehuda St
Tel Aviv, 6340108
Israel
Tel Aviv, 6340108
Israel
Phone
Undisclosed
Website
Email Address
Overview
We are a cross-disciplinary group of entrepreneur-scientists that came together in 2020 to usher in the next generation of RNAi technologies. Coming from leading academic institutions, well-established pharma companies, and high-stress military environments, we share the single goal of creating scalable processes to program RNAi therapies, focusing initially on treating respiratory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yaniv Erlich
Chief Operating Officer
Shaul Ilan
Chief Scientific Officer
Greg Hannon
Browse more venture capital transactions:
Prev: 8/1/2022: Differentiated Therapeutics venture capital transaction
Next: 8/2/2022: Sironax venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs